HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014.

about

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014.

Item

http://www.wikidata.org/entity/Q36282702

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@ast

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@en

type

Item

label

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@ast

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@en

prefLabel

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@ast

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@en

P1476

HIV drug therapy duration; a S ...... study on InfCareHIV 2009-2014.

@en

P2093

Amanda Häggblom

http://www.w3.org/2001/XMLSchema#string

Amy Leval

http://www.w3.org/2001/XMLSchema#string

Andreas Palmborg

http://www.w3.org/2001/XMLSchema#string

Bo Hejdeman

http://www.w3.org/2001/XMLSchema#string

Eva Herweijer

http://www.w3.org/2001/XMLSchema#string

Leo Flamholc

http://www.w3.org/2001/XMLSchema#string

Magnus Gisslén

http://www.w3.org/2001/XMLSchema#string

Stefan Lindbäck

http://www.w3.org/2001/XMLSchema#string

Sverrir Valgardsson

http://www.w3.org/2001/XMLSchema#string

Veronica Svedhem

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data.

Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks.

Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

High Concordance between Self-Reported Adherence, Treatment Outcome and Satisfaction with Care Using a Nine-Item Health Questionnaire in InfCareHIV

A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

P304

e0171227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0171227

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28207816

http://www.w3.org/2001/XMLSchema#string

P921

An t-Suain

P932

5313128

http://www.w3.org/2001/XMLSchema#string